{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:43:18Z","timestamp":1791265398321,"version":"4.1.0"},"reference-count":67,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T00:00:00Z","timestamp":1428451200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet Pharm &amp; Therapeutics"],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:p>Antimicrobials are essential medicines for the treatment of many microbial infections in humans and animals. Only a small number of antimicrobial agents with new mechanisms of action have been authorized in recent years for use in either humans or animals. Antimicrobial resistance (<jats:styled-content style=\"fixed-case\">AMR<\/jats:styled-content>) arising from the use of antimicrobial agents in veterinary medicine is a concern for public health due to the detection of increasing levels of resistance in foodborne zoonotic bacteria, particularly gram\u2010negative bacteria, and due to the detection of determinants of resistance such as Extended\u2010spectrum beta\u2010lactamases (<jats:styled-content style=\"fixed-case\">ESBL<\/jats:styled-content>) in bacteria from animals and in foodstuffs of animal origin. The importance and the extent of the emergence and spread of <jats:styled-content style=\"fixed-case\">AMR<\/jats:styled-content> from animals to humans has yet to be quantified. Likewise, the relative contribution that the use of antimicrobial agents in animals makes to the overall risk to human from <jats:styled-content style=\"fixed-case\">AMR<\/jats:styled-content> is currently a subject of debate that can only be resolved through further research. Nevertheless, risk managers have agreed that the impact on public health of the use of antimicrobials in animals should be minimized as far as possible and a variety of measures have been introduced by different authorities in the <jats:styled-content style=\"fixed-case\">EU<\/jats:styled-content> to achieve this objective. This article reviews a range of measures that have been implemented within European countries to reduce the occurrence and the risk of transmission of <jats:styled-content style=\"fixed-case\">AMR<\/jats:styled-content> to humans following the use of antimicrobial agents in animals and briefly describes some of the alternatives to the use of antimicrobial agents that are being developed.<\/jats:p>","DOI":"10.1111\/jvp.12226","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T05:15:20Z","timestamp":1428556520000},"page":"519-528","source":"Crossref","is-referenced-by-count":20,"title":["The management of risk arising from the use of antimicrobial agents in veterinary medicine in EU\/EEA countries \u2013 a review"],"prefix":"10.1111","volume":"38","author":[{"given":"K.","family":"T\u00f6rneke","sequence":"first","affiliation":[{"name":"L\u00e4kemedelsverket Uppsala Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Torren\u2010Edo","sequence":"additional","affiliation":[{"name":"European Medicines Agency London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Grave","sequence":"additional","affiliation":[{"name":"European Medicines Agency London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. K. J.","family":"Mackay","sequence":"additional","affiliation":[{"name":"European Medicines Agency London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,4,8]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2005.pto960401.x"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.71.7.726"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00019-0"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2006.02.006"},{"key":"e_1_2_8_6_1","unstructured":"Beemer F. Velzen G. Berg C. Zunderdorp M. Lambrechts E. Gier K.&Oud N.(2010).What would be the effects of decoupling the prescription and sale of veterinary medicines by veterinarians?(Berenschot report).http:\/\/www.fve.org\/uploads\/publications\/docs\/berenschot%20report_02_2010.pdf."},{"key":"e_1_2_8_7_1","unstructured":"BSAVA(2013).Responsible use of antimicrobial agentshttp:\/\/www.bsava.com\/Advice\/BSAVAGuidetotheUseofVeterinaryMedicines\/Responsibleuseofantimicrobialagents\/tabid\/363\/Default.aspx."},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1089\/fpd.2007.0057"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg313"},{"key":"e_1_2_8_10_1","volume-title":"Code of Practice to Minimize and Contain Antimicrobial Resistance (CAC\/RCP 61\u20102005)","author":"Codex Alimentarius","year":"2009"},{"key":"e_1_2_8_11_1","unstructured":"Danish Veterinary and Food Administration(2013a).Evidence\u2010based prudent use guidelines for antimicrobial treatment of pigs.http:\/\/www.foedevarestyrelsen.dk\/english\/Pages\/default.aspx."},{"key":"e_1_2_8_12_1","unstructured":"Danish Veterinary and Food Administration(2013b).Special provisions for the reduction of the consumption of antibiotics in pig holdings (the yellow card initiative) http:\/\/www.foedevarestyrelsen.dk\/english\/SiteCollectionDocuments\/25_PDF_word_filer%20til%20download\/Yellow%20Card%20Initiative.pdf."},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/vr.101454"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prevetmed.2006.11.001"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2009.08.009"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr367"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2011.02.012"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1601.090729"},{"key":"e_1_2_8_19_1","unstructured":"ECDC EFSA&EMEA(2009).Joint scientific report of ECDC EFSA and EMEA on meticillin resistant Staphylococcus aureus (MRSA) in livestock companion animals and food. Summary of the scientific Opinion of the Panel on Biological Hazards (EFSA\/BIOHAZ) on \u201cAssessment of the Public Health significance of meticillin resistant Staphylococcus aureus (MRSA) in animals and foods\u201d and the Reflection paper of the Committee for Medicinal Products for Veterinary Use (EMEA\/CVMP) on \u201cMRSA in food producing and companion animals and in the European Union: Epidemiology and control options for human and animal health\u201d http:\/\/www.ema.europa.eu\/ema\/pages\/includes\/document\/open_document.jsp?webContentId=WC500004306."},{"key":"e_1_2_8_20_1","unstructured":"ECDC EFSA&EMEA(2015).First joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food\u2010producing animals http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Report\/2015\/01\/WC500181485.pdf."},{"key":"e_1_2_8_21_1","first-page":"2154","article-title":"Trends and sources of zoonoses and zoonotic agents and food\u2010borne outbreaks in 2009","volume":"9","author":"EFSA\/ECDC","year":"2011","journal-title":"EFSA Journal"},{"key":"e_1_2_8_22_1","unstructured":"EFSA\/ECDC(2012).The European Union Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from humans animals and food in 2010. http:\/\/www.efsa.europa.eu\/en\/efsajournal\/doc\/2598.pdf."},{"key":"e_1_2_8_23_1","unstructured":"EMA\/CVMP(2011).CVMP strategy on antimicrobials 2011\u20132015 (EMA\/CVMP\/287420\/2010) http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Report\/2011\/07\/WC500109137.pdf."},{"key":"e_1_2_8_24_1","unstructured":"EMA\/CVMP\/SAGAM(2011).Reflection paper on the use of macrolides lincosamides and streptogramins (MLS) in food\u2010producing animals in the European Union: development of resistance and impact on human and animal health http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2011\/11\/WC500118230.pdf."},{"key":"e_1_2_8_25_1","unstructured":"EMA\/ESVAC(2013).European Medicines Agency. Sales of veterinary antimicrobial agents in 25 EU\/EEA countries in 2011 (EMA\/236501\/2013) http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Report\/2013\/10\/WC500152311.pdf."},{"key":"e_1_2_8_26_1","unstructured":"EMA\/ESVAC(2014).European Medicines Agency. Sales of veterinary antimicrobial agents in 26 EU\/EEA countries in 2012 (EMA\/333921\/2014) http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Report\/2014\/10\/WC500175671.pdf."},{"key":"e_1_2_8_27_1","unstructured":"EMEA\/CVMP\/SAGAM(2007).Public statement on the use of (fluoro)quinolones in food\u2010producing animals in the European Union: development of resistance and impact on human and animal health http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Public_statement\/2009\/10\/WC500005152.pdf."},{"key":"e_1_2_8_28_1","unstructured":"EMEA\/CVMP\/SAGAM(2009a).Reflection paper on MRSA in food producing and companion animals in the European Union: epidemiology and control options for human and animal health (EMEA\/CVMP\/SAGAM\/68290\/2009) http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/10\/WC500004311.pdf"},{"key":"e_1_2_8_29_1","unstructured":"EMEA\/CVMP\/SAGAM(2009b).Revised reflection paper on the use of 3rd and 4th generation cephalosporins in food producing animals in the European Union: development of resistance and impact on human and animal health http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/10\/WC500004307.pdf."},{"key":"e_1_2_8_30_1","unstructured":"EPRUMA(2013).European Platform for responsible use of medicines in animalshttp:\/\/www.epruma.eu\/."},{"key":"e_1_2_8_31_1","unstructured":"European Commission(2011).Communication from the Commission to the European Parliament and the Council: Action plan against the rising threats from antimicrobial resistance (2011) http:\/\/ec.europa.eu\/dgs\/health_consumer\/docs\/communication_amr_2011_748_en.pdf."},{"key":"e_1_2_8_32_1","unstructured":"European Commission(2012).A decade of EU\u2010funded Animal Health. Research Development of new integrated strategies for prevention control and monitoring of epizootic poultry diseases. Project no.: SSPE\u2010CT\u20102004\u2010513737: Chapter 4 Trade in live poultry within the European Union http:\/\/www.discontools.eu\/upl\/1\/default\/doc\/186225_2011_2696_ANIMAL_HEALTH_RESEARCH_EN.pdf"},{"key":"e_1_2_8_33_1","unstructured":"European Parliament(2011).European Parliament resolution of 27 October 2011 on the public health threat of antimicrobial resistance (2011\/C 315\/01) http:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=OJ:C:2011:315:0001:0003:EN:PDF"},{"key":"e_1_2_8_34_1","unstructured":"European Parliament(2012a).European Parliament resolution of 11 December 2012 on the Microbial Challenge \u2013 Rising threats from Antimicrobial Resistance (2012\/2041(INI) http:\/\/www.europarl.europa.eu\/sides\/getDoc.do?pubRef=-\/\/EP\/\/TEXT+TA+20121211+ITEMS+DOC+XML+V0\/\/EN{00AMP00}language=EN#sdocta18."},{"key":"e_1_2_8_35_1","unstructured":"European Parliament(2012b).European Parliament resolution of 12 May 2011 on antibiotic resistance (2012\/C 377 E\/17) published on 7 December 2012 http:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=OJ:C:2012:377E:0131:0135:EN:PDF."},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1086\/429323"},{"key":"e_1_2_8_37_1","unstructured":"FDA(2005).Enrofloxacin for Poultry; Final Decision on Withdrawal of New Animal Drug Application Following Formal Evidentiary Public Hearing; Availability. Docket No. 2000N\u20101571 http:\/\/www.gpo.gov\/fdsys\/pkg\/FR-2005-08-01\/html\/05-15224.htm."},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks108"},{"key":"e_1_2_8_39_1","unstructured":"French Directorate\u2010General for Food(2013).The \u00e9coantibio 2017 plan. Reducing antibiotic use in veterinary medicine http:\/\/agriculture.gouv.fr\/IMG\/pdf\/130208PlaqAntibioGB_BD_cle022cc4.pdf."},{"key":"e_1_2_8_40_1","unstructured":"FVE(2012a).How to use antimicrobials responsibly: advice for veterinarians http:\/\/www.fve.org\/uploads\/publications\/docs\/fve_antimicrobials_a3_hr03.pdf."},{"key":"e_1_2_8_41_1","unstructured":"FVE(2012b).How we can safeguard antimicrobials now and for the future http:\/\/www.fve.org\/uploads\/publications\/docs\/fve_antimicrobials_a4_hr02.pdf."},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prevetmed.2006.02.003"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh332"},{"key":"e_1_2_8_44_1","unstructured":"Heads of Medicines Agencies(2013).Heads of Medicines Agencies.http:\/\/www.hma.eu\/."},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/1751-0147-50-28"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvjl.2010.03.003"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2672.1999.00853.x"},{"key":"e_1_2_8_48_1","first-page":"85","article-title":"Dealing with MRSA in companion animals practice","volume":"17","author":"Lloyd D.H.","year":"2007","journal-title":"European Journal of Companion Animal Practice"},{"key":"e_1_2_8_49_1","unstructured":"MARAN(2012).Trends in veterinary antibiotic use in the Netherlands 2004\u20132012.http:\/\/www.wageningenur.nl\/upload\/e4deb048-6a0c-401e-9620-fab655287fbc_Trends%20in%20use%202004-2012.pdf."},{"key":"e_1_2_8_50_1","first-page":"365","article-title":"Reduction of antibacterial drug use in Norwegian fish farming due to vaccination","volume":"90","author":"Markestad A.","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"e_1_2_8_51_1","unstructured":"Marquer P.(2010a).Pig farming in the EU a changing sector http:\/\/www.eds-destatis.de\/de\/downloads\/sif\/sf_10_008.pdf."},{"key":"e_1_2_8_52_1","first-page":"1","article-title":"Pig Farming in the EU, a Changing Sector","author":"Marquer P.","year":"2010","journal-title":"Statistics in focus. Eurostat"},{"key":"e_1_2_8_53_1","unstructured":"Norm\u2010Vet 2011(2012).Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway. Troms\u00f8 \/ Oslo http:\/\/www.vetinst.no\/content\/download\/9684\/118231\/file\/NORM_NORM-VET_2011_Korrigert.pdf."},{"key":"e_1_2_8_54_1","unstructured":"OIE(2013).OIE One Health http:\/\/www.oie.int\/for-the-media\/onehealth\/."},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1707.110209"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01443-12"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1093\/ps\/82.4.627"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268810001524"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002945"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2012.00399"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.2460\/javma.234.12.1530"},{"key":"e_1_2_8_62_1","unstructured":"Swann M.J.(1969).Joint committee on the use of antibiotics in animal husbandry and veterinary medicine. Report Cmnd. 4190.Her Majesty's Stationery Office London."},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2010.11.012"},{"key":"e_1_2_8_64_1","unstructured":"WHO(2011).WHO list of Critically important antimicrobials in human medicine. Third revision http:\/\/apps.who.int\/iris\/bitstream\/10665\/77376\/1\/9789241504485_eng.pdf."},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2011.09.009"},{"key":"e_1_2_8_66_1","unstructured":"World Organisation for Animal Health (OIE)(2012).Terrestrial Animal Health Code http:\/\/www.oie.int\/international-standard-setting\/terrestrial-code\/access-online\/."},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0043933909000087"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.11.034"}],"container-title":["Journal of Veterinary Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvp.12226","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvp.12226","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvp.12226","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:28:50Z","timestamp":1696224530000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jvp.12226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,8]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.1111\/jvp.12226"],"URL":"https:\/\/doi.org\/10.1111\/jvp.12226","archive":["Portico"],"relation":{},"ISSN":["0140-7783","1365-2885"],"issn-type":[{"value":"0140-7783","type":"print"},{"value":"1365-2885","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,8]]}}}